Cetirizine Hydrochloride Tablet, Film Coated
Product Images NDC 45802-919

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride (NDC 45802-919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Perrigo Cetirizine Hydrochloride Tablets (09 20 16 4h239rtc3)

Perrigo Cetirizine Hydrochloride Tablets (09 20 16 4h239rtc3)
This is a description of an antihistamine medication that provides relief for allergy symptoms such as sneezing, itchy and watery eyes, and runny nose. The active ingredient in the drug is Cetirizine Hydrochloride, which provides 24-hour relief. This medication is for indoor and outdoor allergies and comes with 30 tablets. The drug facts and instructions for use are provided. Users are cautioned not to use this product if they have ever had an allergic reaction to it or any of its ingredients. It is not recommended for breastfeeding mothers, and people with liver or kidney disease should ask their doctor before use. The medication may cause drowsiness, and users are advised not to engage in activities that require alertness, such as driving. If an allergic reaction occurs, users should stop use and seek medical help immediately. This medication may be covered by insurance plans, including FSA or HSA accounts, private health plans, and Medicaid/Medicare. The medication is distributed by Perrigo in Allegan, MI.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.